Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. ROIV
3. ANET
4. NKE
5. PANW
6. CL
7. SNDK
8. TAP
9. DELL
10. EAT

Go back to Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis
(NASDAQ: ORGO) Delayed: 1.71 +0.07 (4.27%)
Previous Close $1.64    52 Week High $ 
Open $1.65    52 Week Low $ 
Day High $1.73    P/E N/A 
Day Low $1.63    EPS $ 
Volume 665,544